FIP1L1-PGDFRA GENE REARRANGEMENT DETECTION Test
Test Cost: AED 1830.0
Symptoms Diagnosis: Chronic eosinophilic leukemia (CEL) and systemic mastocytosis
Test Components:
- Price: AED 1830.0
- Sample Condition: 4 mL (2 mL min.) whole blood / Bone marrow from 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
- Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery: Sample Mon by 11 am; Report 12 days
Method: PCR
Test Type: Pharmacogenomics
Doctor: Physician
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details:
The FIP1L1-PGDFRA gene rearrangement detection test is a diagnostic test used to identify a specific genetic abnormality in certain types of blood cancers, such as chronic eosinophilic leukemia (CEL) and systemic mastocytosis. This test specifically looks for a rearrangement of the FIP1L1 and PDGFRA genes, which can result in the production of a fusion protein that drives the growth and proliferation of abnormal cells.
The test typically involves analyzing a sample of blood or bone marrow to detect the presence of the FIP1L1-PDGFRA fusion gene. This can be done through various techniques, such as polymerase chain reaction (PCR) or fluorescence in situ hybridization (FISH).
The detection of the FIP1L1-PDGFRA gene rearrangement is important for diagnosing and monitoring certain blood cancers, as it can help guide treatment decisions. In particular, it can help identify patients who may benefit from targeted therapies that specifically target the abnormal fusion protein.
Test Name | FIP1L1-PGDFRA GENE REARRANGEMENT DETECTION Test |
---|---|
Components | |
Price | 1830.0 AED |
Sample Condition | 4 mL (2 mL min.)whole blood \/ Bone marrow from 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
Report Delivery | Sample Mon by 11 am; Report 12 days |
Method | PCR |
Test type | Pharmacogenomics |
Doctor | Physician |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
Test Details |
The FIP1L1-PGDFRA gene rearrangement detection test is a diagnostic test used to identify a specific genetic abnormality in certain types of blood cancers, such as chronic eosinophilic leukemia (CEL) and systemic mastocytosis. This test specifically looks for a rearrangement of the FIP1L1 and PDGFRA genes, which can result in the production of a fusion protein that drives the growth and proliferation of abnormal cells. The test typically involves analyzing a sample of blood or bone marrow to detect the presence of the FIP1L1-PDGFRA fusion gene. This can be done through various techniques, such as polymerase chain reaction (PCR) or fluorescence in situ hybridization (FISH). The detection of the FIP1L1-PDGFRA gene rearrangement is important for diagnosing and monitoring certain blood cancers, as it can help guide treatment decisions. In particular, it can help identify patients who may benefit from targeted therapies that specifically target the abnormal fusion protein. |